-
14621por Prokunina-Olsson, Ludmila, Morrison, Robert D., Obajemu, Adeola, Mahamar, Almahamoudou, Kim, Sungduk, Attaher, Oumar, Florez-Vargas, Oscar, Sidibe, Youssoufa, Onabajo, Olusegun O., Hutchinson, Amy A., Manning, Michelle, Kwan, Jennifer, Brand, Nathan, Dicko, Alassane, Fried, Michal, Albert, Paul S., Mbulaiteye, Sam M., Duffy, Patrick E.“…Genetic polymorphisms within the IFNL3/IFNL4 genomic region, which encodes type III interferons, have been strongly associated with clearance of hepatitis C virus. We hypothesized that type III interferons might be important for the immune response to other pathogens as well. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14622por Monroe-Wise, Aliza, Mbogo, Loice, Guthrie, Brandon, Bukusi, David, Sambai, Betsy, Chohan, Bhavna, Scott, John, Cherutich, Peter, Musyoki, Helgar, Bosire, Rose, Dunbar, Matthew, Macharia, Paul, Masyuko, Sarah, Wilkinson, Eduan, De Oliveira, Tulio, Ludwig-Barron, Natasha, Sinkele, Bill, Herbeck, Joshua, Farquhar, Carey“…INTRODUCTION: Targeted, tailored interventions to test high-risk individuals for HIV and hepatitis C virus (HCV) are vital to achieving HIV control and HCV microelimination in Africa. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14623por Saghir, Sultan A M, AlGabri, Naif A, Alagawany, Mahmoud M, Attia, Youssef A, Alyileili, Salem R, Elnesr, Shaaban S, Shafi, Manal E, Al-shargi, Omar Y A, Al-balagi, Nader, Alwajeeh, Abdullah S, Alsalahi, Omar S A, Patra, Amlan K, Khafaga, Asmaa F, Negida, Ahmed, Noreldin, Ahmed, Al-Amarat, Wesam, Almaiman, Amer A, El-Tarabily, Khaled A, Abd El-Hack, Mohamed E“…Besides the currently available antiviral medications for human immunodeficiency virus (HIV) and hepatitis C virus (HCV), the chloroquine/hydroxychloroquine (CQ/HCQ) regimen with or without azithromycin has been repurposed in China and was recommended by the National Health Commission, China in mid-February 2020. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14624“…Across Australia, rates of infectious syphilis, human immunodeficiency virus (HIV), and hepatitis C infection have increased by 400, 260, and 15% respectively while gonorrhoea decreased 12% in the 5-year period from 2013 to 2017. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14625por Valery, Patricia C., Bernardes, Christina M., Mckillen, Benjamin, Amarasena, Samath, Stuart, Katherine A., Hartel, Gunter, Clark, Paul J., Skoien, Richard, Rahman, Tony, Horsfall, Leigh, Hayward, Kelly, Gupta, Rohit, Lee, Andrew, Pillay, Leshni, Powell, Elizabeth E.“…Primary liver disease etiology was alcohol in 37.6% of patients, chronic viral hepatitis C in 25.5%, and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) in 23.8%. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14626“…While the pooled prevalence of hepatitis C virus infection using the random-effects model was 5.58% (95% CI 3.55–7.61) with a significant level of heterogeneity (I(2) = 95.1%; p < 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14627por Jeong, Dahn, Karim, Mohammad Ehsanul, Wong, Stanley, Wilton, James, Butt, Zahid Ahmad, Binka, Mawuena, Adu, Prince Asumadu, Bartlett, Sofia, Pearce, Margo, Clementi, Emilia, Yu, Amanda, Alvarez, Maria, Samji, Hasina, Velásquez García, Héctor Alexander, Abdia, Younathan, Krajden, Mel, Janjua, Naveed Zafar“…INTRODUCTION: Increasing evidence indicates that chronic hepatitis C virus (HCV) infection is associated with higher risk of diabetes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14628por Chen, Jui-ping, Chang, Chih-hsiang, Lin, Yu-chih, Lee, Sheng-hsun, Shih, Hsin-nung, Chang, Yuhan“…To evaluate it, we set the primary outcome as infection recurrence, and the secondary outcome as the difference between patients diagnosed with hepatitis B virus or hepatitis C virus. PATIENTS AND METHODS: Between June, 2010 and December, 2016, 172 patients with knee PJIs were treated with two-stage exchange arthroplasty at our institute. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14629“…Unfortunately, the lack of screening methods for viral pathogens resulted in people with hemophilia (PWH) receiving concentrates contaminated by hepatitis A virus, hepatitis C virus, and human immunodeficiency virus, as these concentrates were made from large industrial pools of plasma derived from thousands of donors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14630por Pan, Yang-Xun, Sun, Xu-Qi, Hu, Zi-Li, Xie, Wa, Nie, Ke-Xin, Fang, Ai-Ping, Zhang, Ying-Yao, Fu, Yi-Zhen, Chen, Jin-Bin, Wang, Jun-Cheng, Wang, Xin, Zhang, Yao-Jun, Hu, Dan-Dan, Chen, Min-Shan“…BACKGROUND: The importance of alpha-fetoprotein (AFP) and des-gamma-carboxyprothrombin (DCP) in hepatocellular carcinoma (HCC) has been studied extensively in Japan, where hepatitis C virus is the predominant aetiology of HCC. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14631por Meyer, Nicholas, Cooper, Wendy, Kirwan, Paul, Garsia, Roger, Dunkley, Scott, Gracey, David M.“…BACKGROUND: Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) cause a wide range of glomerular pathologies. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14632por Beykaso, Gizachew, Teklehaymanot, Tilahun, Giday, Mirutse, Berhe, Nega, Doyore, Feleke, Alemayehu, Dawit Hailu, Mihret, Adane, Mulu, Andargachew“…Data were collected using a structured questionnaire and laboratory blood screening for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) using Wantai AiDTM HBsAg, anti-HCV, and HIV 1 + 2 Ag/Ab ELISA. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14633por Martínez-Rebollar, María, De La Mora, Lorena, Campistol, Miriam, Cabrera, Bruno, Bagué, Albert, De Lazzari, Elisa, Torres, Berta, González-Cordón, Ana, Inciarte, Alexy, Ambrosioni, Juan, Martínez, Esteban, Blanco, José L., Forns, Xavier, Blanch, Jordi, Mallolas, Josep, Laguno, Montserrat“…INTRODUCTION: The objective of the present study is to describe the incidence of recently acquired hepatitis C (RAHCV) in a large cohort of people living with HIV (PLWHIV) and sexualized drug use and other related risk behaviours. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14634por Chouikha, Anissa, Ghrabi, Amine, Ghodbane, Amira, Hammemi, Walid, Khedhiri, Marwa, Sadraoui, Amel, Touzi, Henda, Hassine, Hichem Ben, Maatoug, Sonia, Bensaoud, Chaima, Abdelhak, Sonia, Bouarrouj, Samir, Gdoura, Mariem, Chaouachi, Hedia, Triki, Henda“…Little is known about the distribution of hepatitis C virus (HCV) genotypes among people who inject drugs (PWID) in North African countries, including Tunisia. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14635por Jongen, Vita W, Reyniers, Thijs, Ypma, Zorah MH, Schim van der Loeff, Maarten F, Davidovich, Udi, Zimmermann, Hanne ML, Coyer, Liza, van den Elshout, Mark AM, de Vries, Henry JC, Wouters, Kristien, Smekens, Tom, Vuylsteke, Bea, Prins, Maria, Laga, Marie, Hoornenborg, Elske“…In both projects, participants could choose between daily and edPrEP at three‐monthly study visits, when they were also screened for sexually transmitted infections including hepatitis C (HCV). We assessed the proportion choosing each regimen, and the determinants of choosing edPrEP at baseline. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14636por Deguchi, Sayaka, Shintani, Tomohiro, Harada, Kazuo, Okamoto, Toru, Takemura, Akinori, Hirata, Kazumasa, Ito, Kousei, Takayama, Kazuo, Mizuguchi, Hiroyuki“…Finally, we examined whether the therapeutic effects of an anti‐hepatitis C virus (HCV) drug metabolized by CYP3A4 would be predicted using our model. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14637por Israr, Muhammad, Ali, Fawad, Nawaz, Arif, Idrees, Muhammad, Khattak, Aishma, Ur Rehman, Shafiq, Azizullah, Azizullah, Ahmad, Bashir, Bano, Syeda Asma, Iqbal, Rashid“…This cross-sectional study was designed to investigate the seroepidemiology and associated risk factors of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among 375 pregnant women attending antenatal care health facilities at Bacha Khan Medical Complex (BKMC) Shahmansoor and District Head Quarter (DHQ) Hospital Swabi, Khyber Pakhtunkhwa, Pakistan. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14638por Alqahtani, Saeed Mohammed, A. Alsagaby, Suliman, Mir, Shabir Ahmad, Alaidarous, Mohammed, Bin Dukhyil, Abdulaziz, Alshehri, Bader, Banawas, Saeed, Alturaiki, Wael, Alharbi, Naif Khalaf, Azad, Taif Anwar, Al Abdulmonem, Waleed“…Aim of the study: This study aimed to determine the prevalence of hepatitis B and hepatitis C viral infections among blood donors in the northern region of Riyadh, Saudi Arabia. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14639por Sato, Shinya, Namisaki, Tadashi, Murata, Koji, Fujimoto, Yuki, Takeda, Soichi, Enomoto, Masahide, Shibamoto, Akihiko, Ishida, Koji, Ogawa, Hiroyuki, Takagi, Hirotetsu, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Inoue, Takashi, Sawada, Yasuhiko, Nishimura, Norihisa, Kitagawa, Koh, Ozutsumi, Takahiro, Takaya, Hiroaki, Kaji, Kosuke, Shimozato, Naotaka, Kawaratani, Hideto, Moriya, Kei, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi“…Patients (n = 193) included in a discovery cohort (January 2011 and December 2014) were categorized into alcoholic (A1; n = 55) and non-alcoholic cirrhosis (NA; n = 138) groups, and those (n = 235) in a validation cohort (January 2015 to December 2019) were categorized into alcoholic (n = 92), non-alcoholic steatohepatitis-related (n = 27), and hepatitis C virus-related cirrhosis groups (n = 116). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14640“…BACKGROUND: Previous studies reported worsened lipid profiles in patients infected with hepatitis C virus (HCV) during direct-acting antivirals (DAAs) treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto